fda compounding semaglutide warning september 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Out of Shortage, Into Controversy:

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b trial

The additional GIP and glucagon activity creates distinct metabolic effects: Ozempic: Appetite suppression via GLP-1, delayed gastric emptying Retatrutide: Appetite suppression + enhanced energy expenditure + hepatic lipid oxidation Researchers studying GLP-1 in isolation use semaglutide

Common side effects on Wegovy The most frequent side effects in STEP 1 were stomach and gut symptoms: nausea, diarrhoea, vomiting, and constipation

Both drugs are synthetic versions of those hormones, designed to activate specific receptors in the body

PlexusDx providers conduct regular check-ins to assess your tolerance, adjust your dose if needed, and address any concerns

Pavlovic N, Tcheugui JE, &Ndumele CE